Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025. Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform & Consumable" provides Next Generation Sequencing Market. Access full Research: https://www.renub.com/next-generation-sequencing-market-p.php
The global next generation sequencing (NGS) services market is estimated to garner a revenue of USD 18,000.0 Million by the end of 2033 by growing at a CAGR of ~20% over the forecast period, i.e., 2023 – 2033
Global Market Insights Inc. Add New Report Global Next Generation Sequencing Market to its database which covers the market landscape and its growth prospects over the coming years.
The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry.
Major players in the next generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., BGI Group, Agilent Technologies Inc...@ @ https://bit.ly/3H8wBgc
This report focuses on the global Next-Generation Sequencing Informatics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next-Generation Sequencing Informatics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Global Next Generation Sequencing Market by The Business Research Company is segmented as NextSeq Systems, MiniSeq Systems, NovaSeq Systems, iSeq 100 Systems, Ion PGM Systems, Ion Proton Systems, Ion GeneStudio S5 Systems https://bit.ly/3xBiA6f
A market analysis looks at the effectiveness of the Next Generation Sequencing Services market in 2023. It includes a thorough examination of the worldwide competitive environment and the state of the Interven Next Generation Sequencing Services market. Through market information such as growth factors, recent advancements, company strategies for Next Generation Sequencing Services market, regional studies, and future market status, it is possible to acquire the Global Next Generation Sequencing Services market.
Next Generation Sequencing (NGS) Data Analysis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Sequencing (NGS) Data Analysis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
This report focuses on the global Next Generation Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Next-generation sequencing (NGS) market is set to witness substantial growth through 2032 owing to the increasing use of the technology for diverse pharmaceutical & biopharmaceutical applications.
Next-Generation sequencing Market research report is the new statistical data source added by Adroit Market Research. “Next-Generation sequencing Market is growing at a High CAGR during the forecast period 2024-2031. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market”.
Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-clinical-oncology-next-generation-sequencing-market
According to the Market Statsville Group (MSG), the global next generation sequencing market size is expected to grow from USD 9,345.0 million in 2022 to USD 58,254.4 million by 2033, at a CAGR of 18.1% from 2023 to 2033.
According to the latest research report by IMARC Group, The United States next generation sequencing market size is projected to exhibit a growth rate (CAGR) of XX% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-next-generation-sequencing-market
The DNA next generation sequencing market size is estimated to reach US$ 22,716.9 million by 2025 from US$ 4,898.5 million in 2017; it is expected to grow at a CAGR of 21.7% during 2018-2025.
Clinical Oncology Next-generation Sequencing Market: Launch of Low-cost Sequencing Platforms to Accelerate Adoption: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
TBRC global clinical oncology next generation sequencing market report includes ion semiconductor sequencing, pyro-sequencing, synthesis sequencing, real time sequencing.
iGATE Research has released a research report on “Global Next Generation Sequencing (NGS) Market (By Products - Consumables, Platforms, Services, Sequencing Services, Bioinformatics, Technology, Applications, End Users, Regions), Key Company Profiles - Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=165 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The major competitors covered in the next generation sequencing market report are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc. Read More @ http://bit.ly/3r0A7S
The major competitors covered in the next generation sequencing market report are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc. Read More @ http://bit.ly/3r0A7SB
This report broadly segments the global next generation sequencing market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics.
A recent report published by The Business Research Company on Next Generation Sequencing Market provides in-depth analysis of segments and sub-segments in the global as well as regional.
Clinical Oncology Next-generation Sequencing Market: Launch of Low-cost Sequencing Platforms to Accelerate Adoption: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
The rise in technological advancements, especially nanopore sequencing in NGS and rise in the need to improve diagnostic procedures and ensure quality treatment is propelling the development is propelling the development of next generation sequencing market.
The Global And China Next Generation Sequencing Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Next Generation Sequencing industry.
The major player covered in the clinical oncology next generation sequencing global market report are Thermo Fisher Scientific(Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics,
Next Generation Sequencing platforms are helpful in diagnosis and analysis of rare diseases as well as prenatal testing and identifying therapeutic with the advancement in bioinformatics. Contact a Sample Report at info@renub.com
However, accuracy & standardization concerns in diagnostic testing, lack of skilled professionals, and ethical & legal issues related to NGS are some of the key factors restraining the growth of this market. In addition to this, challenges associated with interpretation of complex data from NGS platforms and storage of sequencing data also limits the growth of the NGS market.
Next-generation Sequencing (NGS) Market : Opportunities The effect of the driving variables is relied upon to defeat the impact of limitations. In addition, the usage of distributed computing in NGS for information the executives and undiscovered rising economies are required to give new market chances to next generation sequencing makers sooner rather than later.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100000820 According to a new market research study titled 'Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.
AdroitMarketResearch.com just released a new market research report focusing on the “Next-Generation Sequencing Services Market Market with Global analysis and forecasts until 2025” to its database.
"Global Next Generation Sequencing Market 2015-2019" :Big MarketReseach.Thise Report Offer Next Generation Sequencing Market-Size,Share,Forecast,Analysis,research and Report. To Get Complete Report @http://www.bigmarketresearch.com/global-next-generation-sequencing-2015-2019-market Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. This analysts forecast the global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019. Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/222192
The global Cancer/Tumor Profiling market is poised to reach USD 61.87 billion by 2021 from USD 25.82 billion in 2016, at a CAGR of 19.1% from 2016 to 2021. Increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research are the major factors driving the growth of the global Cancer/Tumor Profiling market.
In 2013, the installed capacity of global wind power reached 318.137GW. And the top five of the installed capacity in the world in sequence are China, America, Germany, Spain and India. In the past five years (from 2009 to 2013), the size of global wind power generation market has expanded by nearly 200GW. After two consecutive years’ industrial adjustment, the wind power generation has stepped into an ordered development track under the powerful policy intervention. In 2013, the newly increased installed capacity of wind power was 16.10 million KW, increasing by 24% compared that of 2012, which was 12.96 million KW. By now, China’s accumulated installed capacity of wind power has exceeded 90 million KW, reaching 91.4242 million KW.
The global next-generation gynecological cancer diagnostics market size was valued at USD 2.18 billion in 2021. It is expected to reach USD 5.45 billion by 2030, growing at a CAGR of 10.68% during the forecast period (2022–2030) For more info - https://straitsresearch.com/report/next-generation-gynecological-cancer-diagnostics-market
Next Generation Sequencing Data Analysis Nadia Pisanti, University of Pisa Why sequencing? The knowledge of DNA and RNA sequences has become a crucial tool for: Basic ...
For global markets, the Market analysis is supplied, along with information on development trends, competitive landscape analysis, and the state of development of major regions. According to straits research the Next-Generation Sequencing (NGS) Market Market will grow at a CAGR of 21.6% during the forecast period.
According to #TechSci Research report, Global Nanopore Sequencing Market stood at USD236.91 million in 2020 and is expected to grow at a robust rate of 15.29% during the forecast period. Gain more Insight: https://bit.ly/2TWAQZ4 Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
The major player covered in the clinical oncology next generation sequencing global market report are Thermo Fisher Scientific(Qiagen), Oxford Nanopore Technologies, QIAGEN,
According to The Insight Partners market research study of “Nucleic Acid Amplification, Detection, and Diagnostics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Nucleic Acid, Process, Product Type, Technology, Application, End User, and Geography”, the global nucleic acid amplification, detection, and diagnostics market is expected to reach US$ 38,162.68 million by 2027 from US$ 14,014.59 million in 2019. The market is estimated to grow at a CAGR of 13.4% from 2020 to 2027. The report highlights trends prevailing in the global nucleic acid amplification, detection, and diagnostics market and the factors driving market along with those that act as hindrances.
The report on Single-cell Analysis Market by type(animal cells, human cells and microbial cells), product type(instruments, consumables), technology(mass spectrometry, microscopy), applications (medical applications, research applications), end-user(hospitals, biotechnology) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Single-cell Analysis Market is projected to grow at a CAGR between 16.5% and 17.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Next-Generation Sequencing Market 2019 Fortune Business Insights report presents you analysis of market size, share, and growth, trends, and cost structure, statistical and comprehensive data of the global market.
The global cell analysis market size reached US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Market Size – USD 1.70 Billion in 2019, Market Growth - CAGR of 17.4%, Market Trends – Growing awareness of carrier screening across the healthcare industry
Short-read Sequencing market garnered a revenue of USD 9.45 billion in the year 2019 globally and has been foreseen to yield USD 20.14 billion by the year 2027 at a compound annual growth (CAGR) of 11.1% over the forecast period.